HemaSphere
(Aug 2023)
P1563: REMDESIVIR USE IN SEVERE AND CRITICAL COVID-19 PATIENTS MIGHT BE ASSOCIATED WITH LOWER INCIDENCE OF ARTERIAL THROMBOTIC EVENTS
- Marko Lucijanic,
- Petra Bistrovic,
- Ana Jordan,
- Iva Mihaljevic,
- Stela Bukvic,
- Stjepan Kovacevic,
- Darjan Ranilovic,
- Sara Sakota,
- Josipa Vlasac Glasnovic,
- Diana Delic-Brkljacic
Affiliations
- Marko Lucijanic
- 1 Clinical Hospital Dubrava, Zagreb, Croatia
- Petra Bistrovic
- 1 Clinical Hospital Dubrava, Zagreb, Croatia
- Ana Jordan
- 1 Clinical Hospital Dubrava, Zagreb, Croatia
- Iva Mihaljevic
- 1 Clinical Hospital Dubrava, Zagreb, Croatia
- Stela Bukvic
- 1 Clinical Hospital Dubrava, Zagreb, Croatia
- Stjepan Kovacevic
- 3 Opća bolnica “Dr. J. Benčević” - Slavonski Brod, Slavonski Brod, Croatia
- Darjan Ranilovic
- 1 Clinical Hospital Dubrava, Zagreb, Croatia
- Sara Sakota
- 1 Clinical Hospital Dubrava, Zagreb, Croatia
- Josipa Vlasac Glasnovic
- 1 Clinical Hospital Dubrava, Zagreb, Croatia
- Diana Delic-Brkljacic
- 4 Sisters of Charity Hospital, Zagreb, Croatia
- DOI
-
https://doi.org/10.1097/01.HS9.0000973128.79769.f1
- Journal volume & issue
-
Vol. 7
p.
e79769f1
WeChat QR code